Blood Glucose Monitoring System Market Comprehensive Study 2019: Medtronic, Abbott, Roche, Johnson & Johnson, PHC HOLDINGS LIMITED , Dexcom, Ypsomed AG, B. Braun Group, Nipro Medical Corporation, Sanofi, ARKRAY Inc., Prodigy Diabetes Care, Bayer, BD

Global Blood Glucose Monitoring System Market report is in-depth study on how the status is for the Monitoring Devices industry. This report includes a study of marketing and development strategies, along with the product portfolios of the leading companies. It also includes profiles of leading companies and brands that are driving the market with their recent developments, product launches, joint ventures, merges, and accusations. The global Blood Glucose Monitoring System Market report also gives a deep knowledge about market definition, classifications, applications, engagements and market trends while also showing the CAGR figures for the Forecast years 2019-2026. SWOT analysis is used to find the market drivers and restrains.

Get Sample Report PDF | at https://databridgemarketresearch.com/reports/global-blood-glucose-monitoring-system-market/

The Global Blood Glucose Monitoring System Market is expected to rise from its initial estimated value of USD 13.9 billion in 2018 to an estimated value of USD 22.3 billion by 2026, registering a CAGR of 6.0% in the forecast period of 2019-2026 due to the rising diabetic population and increasing prevalence of innovative testing methods.

Market Definition: Global Blood Glucose Monitoring System Market

Blood glucose monitoring systems are diagnostics systems that are very important for the care and treatment of diabetes, it is used to measure and monitor the levels of blood sugar in the patients. With the rising prevalence of diabetes and diabetic population across the regions, the importance of blood glucose monitoring system’s demand is very high. These systems usually take blood samples, but with rising innovation and advancements in technology, even blood testing is considered traditional and sensors are deployed for continuous monitoring.

Key Developments in the Market:

• In March, 2018 Medtronic received FDA approval for its continuous glucose monitoring system in people with diabetes aged between 14-75 years, called Guardian Connect.

• In September, 2017 Abbott received approval from FDA for FreeStyle Libre Flash its revolutionary blood glucose monitoring device that didn’t require finger pricking, instead it required a sensor to be worn underneath the skin that could be used for 10 days and for continuous monitoring.

Competitors: Global Blood Glucose Monitoring System Market

• Medtronic,
• Abbott,
• F. Hoffmann-La Roche Ltd,
• Johnson & Johnson Services Inc.,
• PHC Holdings Corporation,
• Dexcom Inc.,
• Ypsomed,
• B. Braun Melsungen AG,
• NIPRO,
• Sanofi,
• ARKRAY Inc.,
• Prodigy Diabetes Care LLC.,
• ACON Laboratories Inc.,
• Nova Biomedical,
• Bayer AG,
• BD,
• Roper Technologies Inc.,
• TERUMO CORPORATION,
• Novo Nordisk A/S.

Table of Contents:

1 Introduction
2 Research Methodologies
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Trends
7 Compliance in Blood Glucose Monitoring System Market
8 Blood Glucose Monitoring System Market, By Service
9 Blood Glucose Monitoring System Market, By Deployment Type
10 Blood Glucose Monitoring System Market, By Organization Size
11 Blood Glucose Monitoring System Market Analyses, By Vertical
12 Geographic Analyses
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa
13 Competitive Landscapes
14 Detailed Company Profiles
15 Related Reports

Get Detailed TOC | At https://databridgemarketresearch.com/toc/?dbmr=global-blood-glucose-monitoring-system-market

Competitive Analysis: Global Blood Glucose Monitoring System Market

The global blood glucose monitoring system market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of blood glucose monitoring system Market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

Primary Respondents:

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report:

• Current and future of global blood glucose monitoring system market outlook in the developed and emerging markets

• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

• Regions/Countries that are expected to witness the fastest growth rates during the forecast period

• The latest developments, market shares, and strategies that are employed by the major market players

Request Analyst Call On https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-blood-glucose-monitoring-system-market

Market Drivers:

• Increasing levels of diabetic population across the world is expected to drive the market growth

• Innovation and advancements in these systems is also expected to drive the market growth

Market Restraints:

• Fluctuating economic distribution in the developing regions is expected to restrain the market as these monitoring systems can be substituted for cheaper ones

• Stringent regulations and decreased lab investments is expected to restrain the market growth

Segmentation: Global Blood Glucose Monitoring System Market

By Product

o Self-Monitoring
 Blood Glucose Meters
 Testing Strips
 Lancets & Lancing Devices

o Continuous

 Sensors
 Transmitters
 Receivers

By Testing Site

o Fingertip
o Alternate Site

By Patient Care Setting

o Self/Home Care
o Hospital
o Clinics

By Application

o Type 2 Diabetes
o Type 1 Diabetes
o Gestational Diabetes

By Geography

North America

o US
o Canada
o Mexico

South America

o Brazil
o Argentina
o Rest of South America

Europe

o Germany
o France
o United Kingdom
o Italy
o Spain
o Russia
o Turkey
o Belgium
o Netherlands
o Switzerland
o Rest of Europe

Asia-Pacific

o Japan
o China
o South Korea
o India
o Australia
o Singapore
o Malaysia
o Indonesia
o Thailand
o Philippines
o Rest of Asia-Pacific

Middle East and Africa

o South Africa
o Egypt
o Saudi Arabia
o United Arab Emirates
o Israel
o Rest of Middle East and Africa

Customization of the Report:

• All segmentation provided above in this report is represented at country level

• All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Note: If You Have Any Special Requirements, Please Let Us Know And We Will Offer You The Report As You Want.
Get Customization and Discount | at https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-blood-glucose-monitoring-system-market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavorsto provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com

This release was published on openPR.